<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03677115</url>
  </required_header>
  <id_info>
    <org_study_id>201707158</org_study_id>
    <nct_id>NCT03677115</nct_id>
  </id_info>
  <brief_title>Thoracic Paravertebral Blocks Using a Combination of Ropivacaine and Dexmedetomidine</brief_title>
  <official_title>Thoracic Paravertebral Blocks Using a Combination of Ropivacaine and Dexmedetomidine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Medical University, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China Medical University, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators designed a study to assess whether thoracic paravertebral blocks using a
      combination of ropivacaine and dexmedetomidine prolong nerve block duration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators designed a study to assess whether thoracic paravertebral blocks using a
      combination of ropivacaine and dexmedetomidine prolong nerve block duration. The effects of
      dexmedetomidine have only been compared at lower doses. This trial examined the effect of
      greater dose of dexmedetomidine on thoracic paravertebral block analgesia duration.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Anticipated">March 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>a single-dose thoracic paravertebral analgesia for postoperative pain control after thoracoscopic lobectomy</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of analgesia duration</measure>
    <time_frame>Change from Baseline to 3 days after surgery</time_frame>
    <description>Change of thoracic paravertebral block analgesia duration</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Thoracic Paravertebral Blocks</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a combination of ropivacaine and dexmedetomidine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>combination of ropivacaine and dexmedetomidine 20 ug every time</description>
    <arm_group_label>dexmedetomidine group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients were included in the study if they were ethnic Chinese,

          -  American Society of Anesthesiologists (ASA) physical status I or II,

          -  candidates for general anesthesia undergoing thoracic surgery

        Exclusion Criteria:

          -  Patients were excluded if they do not want to cooperate with the test,

          -  had a history of radial artery puncture or coronary artery bypass grafting,

          -  had acute vessel trauma,or had been diagnosed with Raynaud' disease,

          -  had suffered from mental or neurological disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>the First Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wen-fei Tan, M.D.,Ph.D</last_name>
      <phone>024-83283100</phone>
      <email>winfieldtan@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 16, 2018</study_first_submitted>
  <study_first_submitted_qc>September 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 19, 2018</study_first_posted>
  <last_update_submitted>March 4, 2019</last_update_submitted>
  <last_update_submitted_qc>March 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>China Medical University, China</investigator_affiliation>
    <investigator_full_name>Wen-fei Tan</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm, Dissecting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

